Amazon Prime Day deals are still alive and well: Save over 50% on Apple, Samsung, Dyson and more
So rally one last time. Throw on those stretchy pants, sip that iced coffee, and get back in the game. You don't have to shop hard — you just have to shop smart.
Truth is, these sales won't last forever. We've already seen prices jump overnight and products vanish. If something catches your eye, don't sleep on it.
Overwhelmed by the sheer number of markdowns? Totally fair. That's why our team of shopping editors has done the dirty work — sorting out the real deals from the hype. No fake markdowns. No 'forever 50% off' nonsense. Just the stuff actually worth buying.
Here are the best Extended Prime Day deals still going strong today. Get 'em before they're gone.
Apple 2025 MacBook Air, 13-Inch ($849, was $999): Near all-time-low price
Sleek Socket ($19, was $27): All-time low price
Charmin Ultra Soft Toilet Paper, 6 Mega Rolls ($7, was $11): Lowest price in months
Rubbermaid Brilliance Food Storage Containers, 2-Pack ($14, was $23): Best price since 2023
Glad Forceflex Trash Bags, 110 count ($20, was $23): Lowest price since 2024
Nutrafol Women's Balance Hair Growth Supplements, 1-Month Supply ($84, was $88): Rare sale
Waterpik Aquarius Water Flosser ($88, was $100): Rare sale
Zulay Kitchen Milk Frother Wand ($6, was $10): Best price of 2025
Longzon 4-in-1 Knife Sharpener ($13, was $21): Near all-time low
EZ-Off Jar Opener ($13, was $20): Best price in years
HexClad Hybrid Nonstick 7-Inch Frying Pan ($87, was $109): Near all-time low
This year, Amazon gave us a generous four-day shopping window (a nice upgrade from the usual two), and while the official event wrapped at 11:59 p.m. PDT on July 11, plenty of top deals are still live. That said, all good things must come to an end eventually, and there's no guarantee how long these lingering discounts will stick around. If you're hoping to score the best savings, don't wait until the last minute — these prices could disappear at any time...
If you have Amazon Prime, you'll get free shipping, of course. Not yet a member? No problem. You can sign up for your free 30-day trial here. (And by the way, those without Prime still get free shipping on orders of $35 or more.)
Samsung Galaxy S25 Ultra, 256GB Smartphone, Unlocked ($950, down from $1,300): Meet Samsung's latest powerhouse, an unlocked Android with a stunning 6.9' display, supercharged Snapdragon 8 Elite processor, and built-in S Pen. Take next-level photos in any lighting thanks to the AI Night Mode Camera and smooth out unwanted background noise with Audio Eraser. You get 12GB RAM, a long-lasting 5000mAh battery, and all the smarts of One UI 7 (Android 15). Portraits look flawless, multitasking is a breeze, and switching from your old device is effortless. One-year US warranty included. Grab it now on Prime Day at its lowest price ever!
Apple iPad mini (A17 Pro), 128GB ($399, down from $499): Small but mighty, the latest iPad mini puts Apple Intelligence, the blazing-fast A17 Pro chip, and an 8.3-inch Liquid Retina display in the palm of your hand. Create, stream, or game on the go with all-day battery life, sharp 12MP front and rear cameras, and speedy Wi-Fi 6E. Touch ID keeps things secure, while 128GB storage means you'll never have to worry about running out of space. And right now, it's available at the lowest price ever, making this the perfect time to upgrade your tech or treat someone special.
Apple 2025 MacBook Air 13-inch Laptop, M4 chip, 16GB/256GB ($849, down from $999): Experience the speed and smarts of Apple's newest MacBook Air, now powered by the cutting-edge M4 chip and built for Apple Intelligence features. Enjoy a vibrant 13.6-inch Liquid Retina display, 16GB of unified memory, and 256GB SSD for seamless multitasking. This ultra-portable laptop offers up to 18 hours of battery life, a 12MP Center Stage camera for crystal-clear calls, and Touch ID for instant, secure access. Connect all your essentials with Thunderbolt 4, MagSafe, and Wi-Fi 6E. Available in a stunning Sky Blue, ready to make work, play, and creativity effortless!
QINLIANF 5-Outlet Extender & Surge Protector with 4 USB Ports ($10, down from $13): Turn a single wall outlet into a power hub with five AC outlets and four USB charging ports (including USB-C). The three-sided design gives you plenty of space for chunky adapters, and a secure screw keeps it firmly attached to the wall. Perfect for busy kitchens, offices, or travel. Built-in surge protection (1680 joules) safeguards your devices, while smart charging ensures every gadget gets the optimal juice. It's ETL certified, compact, and ready for all your home or office charging needs. Lowest price for Prime Day!
Apple AirPods 4 Wireless Earbuds ($89, down from $129): Apple's latest AirPods are all about ease and comfort, redesigned for a better fit, smarter sound, and effortless pairing. Pop them in and enjoy personalized spatial audio that makes every playlist, call, or movie feel immersive, plus voice isolation so you're heard crystal clear even in noisy places. With quick-press controls, Siri on demand, and a sweat/water-resistant build, they're ready for workouts, commutes, or a marathon of your favorite shows. The compact USB-C case delivers up to 30 hours of battery, so you're set for all-day listening. This is the lowest price ever! At 31% off, it's the perfect time to upgrade your everyday audio.
Fitbit Charge 6 Fitness Tracker ($100, down from $160): Take charge of your health and fitness goals with Fitbit's newest tracker, available in black case with black band, gold case with red band, or silver case with white band. Track heart rate right from the elliptical or treadmill, explore 40+ exercise modes with built-in GPS, and get personalized health insights, all from your wrist. Includes both small and large bands for the perfect fit, plus a 6-month Premium membership. At 38% off for Prime Day, it's a smart pick for staying motivated in style.
Samsung 65" Frame QLED 4K Smart TV, 2024 Model ($1,498, down from $1,998): Turn your living room into an art gallery with the Samsung Frame Series QLED TV, now at 25% off for Prime Day. This 65-inch beauty doubles as a brilliant 4K HDR smart TV and a customizable digital art frame, with access to over 2,500 masterpieces from world-class museums. The glare-free matte display, anti-reflection tech, and Dolby Atmos sound make movies and art pop, while the slim-fit wall mount and one-cable design keep everything sleek and tidy. Personalize your space with interchangeable frames and digital mats. This is more than a TV. It's a statement piece.
JBL Go 3 Eco Portable Mini Bluetooth Speaker ($30, down from $40): Don't let the size fool you. This little speaker packs a punch! The JBL Go 3 Eco brings big sound and punchy bass wherever you go, wrapped in a pocket-sized, eco-friendly package made in part with recycled materials. Toss it in your bag and head to the park, pool, or shower. It's totally waterproof and dustproof (IP67 rated). Enjoy up to 5 hours of playtime, easy Bluetooth streaming, and a bold design that looks as good as it sounds.
Beats Solo 4 Wireless Bluetooth On-Ear Headphones ($98, down from $200): Power through your playlists with these sleek, on-ear headphones, featuring up to 50 hours of battery life, plush ear cushions for all-day comfort, and personalized spatial audio that puts you at the center of the sound. One-touch pairing works with both Apple and Android, and a quick 10-minute charge delivers up to 5 hours of playback. With crisp calls, dynamic head tracking, and an ultralight ergonomic design, they're perfect for music, calls, or travel. This is the lowest price ever for the Solo 4. Don't miss your chance to save 51%.
Amazon Fire TV Stick 4K (Newest Model) ($25, down from $50): Elevate movie nights with this top-rated streaming stick, now powered by AI search to help you find content by actor, plot or even famous lines. Enjoy cinematic 4K Ultra HD with Dolby Vision and Dolby Atmos, Wi-Fi 6 for smoother streaming, and quick access to over 1.5 million movies and shows, including thousands of free titles. The Alexa Voice Remote lets you control everything hands-free, while built-in smart home features turn your TV into a hub. At 50% off for Prime Day, this is a serious upgrade for your living room.
Shop Prime Day deals: Amazon Prime Day tech deals | Live: Amazon Prime Day deals | The best Amazon Prime Day deals | Live updates on Amazon Prime Day 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis
SOUTH SAN FRANCISCO, Calif., July 15, 2025--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the Division of Hepatology and Nutrition of the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the completed PORTOLA Phase 2a clinical trial evaluating zetomipzomib, a first-in-class selective immunoproteasome inhibitor, in patients with autoimmune hepatitis (AIH). "We are pleased that the FDA has lifted the partial clinical hold on zetomipzomib in AIH after their review of our comprehensive safety assessment of the zetomipzomib program," said Chris Kirk, PhD, CEO and co-founder of Kezar. "We continue to believe that zetomipzomib has the potential to positively transform the lives of patients living with AIH. We look forward to engaging with the FDA to align on the design of the next clinical trial of zetomipzomib in AIH." Although Kezar has suspended development of zetomipzomib in lupus nephritis (LN) to focus on AIH, the company met with the Independent Data Monitoring Committee (IDMC) for the previously terminated PALIZADE clinical trial to review the safety profile of zetomipzomib. The IDMC has provided Kezar with recommendations for conducting future clinical trials in LN. Based on this feedback and internal analysis of safety data across all clinical studies involving zetomipzomib, Kezar plans to respond to the FDA Division of Rheumatology and Transplant Medicine with a request to lift the clinical hold on zetomipzomib in LN. About Zetomipzomib Zetomipzomib is a novel, first-in-class, selective immunoproteasome inhibitor with broad therapeutic potential across multiple autoimmune diseases. Preclinical research demonstrates that selective immunoproteasome inhibition results in a broad anti-inflammatory response in animal models of several autoimmune diseases, while avoiding immunosuppression. Data generated from completed clinical trials provide evidence that zetomipzomib exhibits a favorable safety and tolerability profile for development in severe, chronic autoimmune diseases. About Autoimmune Hepatitis Autoimmune hepatitis (AIH) is a rare chronic disease in which the immune system attacks the liver and causes inflammation and tissue damage, severely impacting patients' physical health and quality of life. Lifelong maintenance therapy is required to avoid relapse and burdensome adverse effects. If left untreated, AIH can lead to cirrhosis, liver failure and hepatocellular carcinoma. In the United States, AIH affects approximately 100,000 individuals, with incidence rates increasing. The cause of this condition remains unclear, with females affected four times as often as males. Currently, standard of care treatment for AIH is chronic, immunosuppressive treatment with corticosteroids that frequently cause life-altering side effects, including diabetes, osteoporotic fractures and cataracts. There is a significant need for treatment regimens that reduce or remove the need for chronic immunosuppression from use of corticosteroids. About Kezar Life Sciences Kezar Life Sciences is a clinical-stage biopharmaceutical company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases. Zetomipzomib, a selective immunoproteasome inhibitor, is currently being evaluated for autoimmune hepatitis. This product candidate also has the potential to address multiple chronic immune-mediated diseases. For more information, visit and follow us on LinkedIn, Facebook, Twitter and Instagram. Cautionary Note on Forward-looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "can," "should," "expect," "believe," "potential," "anticipate" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on Kezar's expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties that could cause Kezar's clinical development programs, future results or performance to differ materially from those expressed or implied by the forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to, statements about the timing and outcome of regulatory submissions and interactions with the FDA, EMA or any other regulatory agencies with respect to zetomipzomib or Kezar's clinical trials, the initiation of an additional clinical trial of zetomipzomib in AIH, and expectations regarding the removal of the clinical hold of zetomipzomib in LN, and the likelihood of obtaining regulatory approval of zetomipzomib. Many factors may cause differences between current expectations and actual results, including unexpected safety or efficacy data observed during clinical studies, difficulties enrolling and conducting our clinical trials, changes in expected or existing competition, changes in the regulatory environment, the uncertainties and timing of the regulatory approval process, and unexpected litigation or other disputes. Other factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Kezar's filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" contained therein. Except as required by law, Kezar assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. View source version on Contacts Investor and Media Contact:Gitanjali JainSenior Vice President, Investor Relations and External AffairsKezar Life Sciences, Melden Sie sich an, um Ihr Portfolio aufzurufen.
Washington Post
17 minutes ago
- Washington Post
Google partners with Youngkin and offers AI training courses to Virginia job seekers
RESTON, Va. — Republican Gov. Glenn Youngkin announced on Tuesday that Google will partner with his administration to provide free and low-cost artificial intelligence certification courses to Virginians as part of his office's ongoing effort to connect citizens to new jobs amid changes to the state's economy. The partnership, which he has described as an AI career launchpad, will provide Google-sponsored AI training courses for up to 10,000 Virginians at any given time, officials said at Google's office in the northern part of the state.
Entrepreneur
18 minutes ago
- Entrepreneur
Perplexity CEO: AI Coding Tools Transformed the Way We Work
Perplexity CEO Aravind Srinivas said that the startup's engineers are using AI coding tools. AI search engine startup Perplexity internally mandated the use of AI coding tools — and says that its engineers have been noticeably more productive. Perplexity CEO Aravind Srinivas told Y Combinator that the startup "made it compulsory" for its engineers to use AI coding tools such as Cursor or GitHub Copilot. These tools can generate blocks of code and debug programs. Related: AI Is Already Writing About 30% of Code at Microsoft and Google. Here's What It Means for Software Engineers. Srinivas said that Perplexity engineers have seen measurable outcomes so far: Using the tools cuts down on "experimentation time" for new tasks from "three, four days to literally one hour," he said. "That level of change is incredible," Srinivas stated. "The speed at which we can fix bugs and ship to production is crazy." Perplexity's AI search engine reported a 20% month-over-month growth in May with 780 million queries. Perplexity CEO Aravind Srinivas. Photographer: David Paul Morris/Bloomberg via Getty Images Related: Google's CEO Is Spending His Free Time 'Vibe Coding' a Webpage with AI: 'I've Just Been Messing Around' At Bloomberg's Tech Summit in May, Srinivas predicted that within a year, Perplexity would be handling "a billion queries a week." He pointed out that when the AI search engine first got started in 2022, it processed 3,000 queries a day, advancing to 30 million queries a day by May. "It's been phenomenal growth," Srinivas stated at the event. Still, there "are issues," Srinivas said about using AI coding assistants, noting that the tools can introduce new bugs that software engineers aren't familiar with and don't know how to fix. Last week, Perplexity introduced Comet, an AI-powered web browser that takes on Google Search and Google Chrome. Comet uses Perplexity's AI search engine as its default tool, putting the company's core product front and center for users. In May, Perplexity was reportedly in late-stage talks for a $500 million funding round that would value the company at $14 billion. Related: 'Building It Ourselves': Morgan Stanley Created an AI Tool to Fix the Most Annoying Part of Coding. Here's How It Works. Join top CEOs, founders and operators at the Level Up conference to unlock strategies for scaling your business, boosting revenue and building sustainable success.
